Business

Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference

HERCULES, Calif., May 12, 2025--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the 2025 RBC Capital Markets Global Healthcare Conference on Wednesday, May 21, 2025, at 1:35 PM Eastern Time (10:35 AM Pacific Time).

articleBio-rad Laboratories, Inc.May 12, 20251/company/bio-rad-laboratories-inc/news/bio-rads-management-participate-fireside-203000335
Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference

About this update from Bio-rad Laboratories, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/1d7b9db6914948c8d014ecc7775511e6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/f0dn8gm5uNxtmt1wT_FubA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/1d7b9db6914948c8d014ecc7775511e6","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/lpN63CVodSInyRjKiUtqeQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/1d7b9db6914948c8d014ecc7775511e6","width":1024,"height":512}},"lazy":false},{"type":"text","content":"HERCULES, Calif., May 12, 2025--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the 2025 RBC Capital Markets Global Healthcare Conference on Wednesday, May 21, 2025, at 1:35 PM Eastern Time (10:35 AM Pacific Time).","length":469,"tagName":"p"},{"type":"text","content":"A live webcast and subsequent replay of the event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com.","length":138,"tagName":"p"},{"type":"text","content":"About Bio-Rad","length":13,"tagName":"p"},{"type":"text","content":"Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with over 7,500 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.","length":688,"tagName":"p"},{"type":"text","content":"View source version on businesswire.com: https://www.businesswire.com/news/home/20250512920950/...

More updates from Bio-rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.clinical diagnosticsclinical diagnostics productsresearch institutionslife science researchRBC Capital MarketsBUSINESS WIRE